Polymorphonuclear neutrophils and granulocytic myeloid-derived suppressor cells inhibit natural killer cell activity toward Aspergillus fumigatus

Medical Mycology

Volumn 53, Issue 6, 2015, Pages 622-629

  Mueller Leisse, Johanna ^a   Brueggemann, Sabrina ^a   Bouzani, Maria ^a   Schmitt, Anna Lena ^a   Einsele, Hermann ^a   Loeffler, Juergen ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Aspergillus fumigatus; Granulocytic myeloid derived suppressor cells; Interferon ; Invasive aspergillosis; Natural killer cells; Polymorphonuclear neutrophils

Indexed keywords

CD137 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEIN P30;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; GRANULOCYTE; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOREGULATION; INVASIVE ASPERGILLOSIS; K562 CELL LINE; NATURAL KILLER CELL; NEUTROPENIA; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PATHOGEN CLEARANCE; PROTEIN EXPRESSION; SUPPRESSOR CELL; ANIMAL; ASPERGILLOSIS; CELL CULTURE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MOUSE; TUMOR CELL LINE;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL LINE, TUMOR; CELLS, CULTURED; GRANULOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MICE; NEUTROPHILS;

EID: 84942109786     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myv030     Document Type: Article

References (39)

1. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011; 20: 156-174.
2. Bonnett CR, Cornish EJ, Harmsen AG et al. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006; 74: 6528-6539.
3. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982; 38: 487-495.
4. Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-259.
5. Takuma T, Okada K, Uchida Y et al. Invasive pulmonary aspergillosis resulting in respiratory failure during neutrophil recovery from postchemotherapy neutropenia in three patients with acute leukaemia. J Intern Med 2002; 252: 173-177.
6. Todeschini G, Murari C, Bonesi R et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 1999; 29: 453-457.
7. Cornillet A, Camus C, Nimubona S et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577-584.
8. Schmidt S, Tramsen L, Hanisch M et al. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203: 430-435.
9. Bouzani M, Ok M, McCormick A et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J Immunol 2011; 187: 1369-1376.
10. Morrison BE, Park SJ, Mooney JM et al. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Investig 2003; 112: 1862-1870.
11. Steinbach WJ, Stevens DA. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003; 37(Suppl 3): S157-187.
12. Dallegri F, Patrone F, Frumento G et al. Down-regulation of K cell activity by neutrophils. Blood 1985; 65: 571-577.
13. Oberlies J, Watzl C, Giese T et al. Regulation of NK cell function by human granulocyte arginase. J Immunol 2009; 182: 5259-5267.
14. Voigt J, Hunniger K, Bouzani M et al. Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity. J Infect Dis 2014; 209: 616-626.
15. Rieber N, Brand A, Hector A et al. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 2013; 190: 1276-1284.
16. Rodriguez PC, Ernstoff MS, Hernandez C et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69: 1553-1560.
17. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
18. Mencacci A, Montagnoli C, Bacci A et al. CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol 2002; 169: 3180-3190.
19. Fortin C, Huang X, Yang Y. NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol 2012; 189: 1843-1849.
20. Li H, Han Y, Guo Q et al. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membranebound TGF-beta 1. J Immunol 2009; 182: 240-249.
21. Semmlinger A, Fliesser M, Waaga-Gasser AM et al. Fever-range temperature modulates activation and function of human dendritic cells stimulated with the pathogenic mould Aspergillus fumigatus. Med Mycol 2014; 52: 438-444.
22. Shepardson KM, Ngo LY, Aimanianda V et al. Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation. Microbes Infect 2013; 15: 259-269.
23. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-729.
24. Pende D, Parolini S, Pessino A et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999; 190: 1505-1516.
25. Pessino A, Sivori S, Bottino C et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998; 188: 953-960.
26. Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complexr-estricted tumor cell lysis. J Exp Med 1998; 187: 2065-2072.
27. Borrego F, Pena J, Solana R. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Eur J Immunol 1993; 23: 1039-1043.
28. Lozzio BB, Lozzio CB. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk Res 1979; 3: 363-370.
29. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294(1-2): 15-22.
30. Wilcox RA, Tamada K, Strome SE et al. Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol 2002; 169: 4230-4236.
31. Park SJ, Hughes MA, Burdick M et al. Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol 2009; 182: 4306-4312.
32. Hoechst B, Voigtlaender T, Ormandy L et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009; 50: 799-807.
33. Ferlazzo G, Tsang ML, Moretta L et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002; 195: 343-351.
34. Jarahian M, Fiedler M, Cohnen A et al. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog 2011; 7: e1002195.
35. Quintin J, Levitz SM. NKp30 enables NK cells to act naturally with fungi. Cell Host Microbe 2013; 14: 369-371.
36. Harlin H, Hanson M, Johansson CC et al. The CD16-CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J Immunol 2007; 179: 4513-4519.
37. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44-69.
38. Rueff J, Medinger M, Heim D et al. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma. Biol Blood Marrow Transplant 2014; 20: 896-899.
39. Angulo I, de las Heras FG, Garcia-Bustos JF et al. Nitric oxideproducing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood 2000; 95: 212-220.